Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-004820
Filing Date
2017-05-10
Accepted
2017-05-10 16:28:06
Documents
70
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1701152_10q.htm 10-Q 420373
2 EXHIBIT 31.1 t1701152_ex31-1.htm EX-31.1 12123
3 EXHIBIT 31.2 t1701152_ex31-2.htm EX-31.2 12039
4 EXHIBIT 32.1 t1701152_ex32-1.htm EX-32.1 5018
  Complete submission text file 0001571049-17-004820.txt   2710648

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE innl-20170331.xml EX-101.INS 424938
6 XBRL SCHEMA FILE innl-20170331.xsd EX-101.SCH 36660
7 XBRL CALCULATION FILE innl-20170331_cal.xml EX-101.CAL 40834
8 XBRL DEFINITION FILE innl-20170331_def.xml EX-101.DEF 80477
9 XBRL LABEL FILE innl-20170331_lab.xml EX-101.LAB 267487
10 XBRL PRESENTATION FILE innl-20170331_pre.xml EX-101.PRE 195702
Mailing Address UNIT 9, BLOCK D, MONKSLAND BUSINESS PARK MONKSLAND ATHLONE L2 NONE
Business Address UNIT 9, BLOCK D, MONKSLAND BUSINESS PARK MONKSLAND ATHLONE L2 NONE 353(0) 90 6486834
Innocoll Holdings plc (Filer) CIK: 0001660484 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37720 | Film No.: 17830699
SIC: 2834 Pharmaceutical Preparations